Dr. Victor Urzola

Dr. Victor Urzola is a pioneering force at the intersection of regenerative medicine, stem cell science, and human performance optimization. As CEO and Co-Founder of RMI – Regenerative Medicine Institute, based in Escazú, Costa Rica, he leads one of the world’s most advanced regenerative medicine clinics, delivering cutting-edge cellular therapies to high-performance individuals seeking to extend their healthspan and reclaim their biology. A specialist in Plastic, Reconstructive, and Aesthetic Surgery, Microsurgery, and Stem Cell Technologies, Dr. Urzola brings nearly two decades of surgical precision to the rapidly evolving world of regenerative and anti-aging medicine. His academic training spans four countries and some of the world’s most respected institutions — including a residency at the University of Milan, a microsurgery sub-specialty at Henri Poincaré University in France, and fellowships at Stanford University in genetics and genomics, Harvard University in cellular therapies and genetic engineering, and the American Academy of Anti-Aging Medicine. Beyond the clinic, Dr. Urzola has shaped the regulatory landscape of regenerative medicine itself. He is personally responsible for the legalization of stem cell therapies in Costa Rica and authored the national regulatory framework for stem cells and regenerative therapies on behalf of the Costa Rican Ministry of Health — making him not only a practitioner, but an architect of the field. As co-founder of RegenCell and Renew alongside RMI, Dr. Urzola has built an ecosystem dedicated to advancing the science of cellular regeneration and translating it into real-world outcomes for patients. His clinical philosophy is grounded in precision, personalization, and a commitment to pushing the boundaries of what regenerative science can achieve. A former president of the Costa Rican Society of Plastic, Reconstructive, and Aesthetic Surgery, Dr. Urzola is recognized internationally as a thought leader whose work bridges surgical expertise, genomics, and the frontier of longevity medicine. Fluent in Spanish, English, Italian, and French, he engages with a truly global community of researchers, clinicians, and biohackers who share his conviction: that human biology is not fixed, and that the tools to optimize it are already within reach.